I am an assistant attending physicist in the Imaging and Spectroscopic Physics Service of the Department of Medical Physics.
I am working with my colleagues at Memorial Sloan Kettering to develop magnetic resonance techniques that provide novel data and identify clinically relevant biomarkers with the potential to improve patient care.
I studied physics in Germany, with an emphasis on biophysics and medical physics. My graduate research focused on the design and development of detector systems for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Starting with my doctoral research, I acquired extensive knowledge of in vitro and in vivo multi-nuclear magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
In my current research, I am investigating the effects of the tumor microenvironment — characterized by hypoxia (oxygen deprivation), acidic pH, and nutrient deprivation — on breast and prostate tumor metabolism and blood vessel development during tumor progression and treatment. My research employs multi-nuclear MRI/MRS, PET, and optical imaging as well as other techniques to study tumor cells.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ellen Ackerstaff discloses the following relationships and financial interests:
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
View all disclosures